Active Ingredient (In Each Extended-Release Bi-Layer Tablet)
GUAIFENESIN 1200MG
The following Structured Product Label (SPL) was submitted to the FDA by Lodaat Llc for the product Guaifenesin - Odaat (NDC 83139-175). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each extended-release bi-layer tablet), purpose, uses, warnings, otc - keep out of reach of children, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
GUAIFENESIN 1200MG
EXPECTORANT
DO NOT USE
ASK DOCTOR BEFORE USE IF YOU HAVE:
STOP USE AND ASK A DOCTOR IS
IF PREGNANT OR BREAST FEEDING, ASK A HEALTH PROFESSIONAL BEFORE USE.
KEEP OUT OF REACH OF CHILDREN. IN CASE OF OVERDOSE, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER (1-800-222-1222) IMMEDIATELY.
CARBOMER HOMOPOLYMER TYBE B, HYPROMELLOSE, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, SODIUM STARCH GLYCOLATE.
CALL TOLL-FREE +1 630 852 7544
* Please review the disclaimer below.